
Centinel Spine’s prodisc C Vivo and C Nova systems obtain MDR certification
The company has completed registration and certification for its total disc replacement products, which are now CE-marked.

The company has completed registration and certification for its total disc replacement products, which are now CE-marked.

Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but that only buys time. The cancer has an insidious ability to hide enough tumor cells in tissue around the tumor to allow it to return as deadly as ever.

SEOUL, South Korea, Sept. 9, 2025 /PRNewswire/ — Patients who suffer from chronic conditions often require continuous injections of drugs, which is quite painful and often inconvenient.

SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ — Willow Innovations, Inc. (Willow), the Femtech leader and inventor of the first fully in-bra wearable breast pump, is once again revolutionizing the pumping experience with the launch of its newest innovation.

CAMPBELL, Calif., Sept. 9, 2025 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, today announced the commercial release of its new wearable ECG sensor adhesive that improves the detection of p-waves during ambulatory cardiac monitoring

Varian announced its Embozene microspheres have received CE mark for genicular artery embolisation (GAE) to treat knee osteoarthritis.

ARC‑EX is the first system to receive a CE Mark in Europe specifically for improving hand and arm strength and sensation in adults with chronic, incomplete spinal cord injury.

Researchers have developed a material that can sense tiny changes within the body, such as during an arthritis flareup, and release drugs exactly where and when they are needed.

Physicians rely on nuclear medicine scans, like SPECT scans, to watch the heart pump, track blood flow and detect diseases hidden deep inside the body. But today’s scanners depend on expensive detectors that are difficult to make.

Indiana University School of Medicine scientists have developed a new method that shifts the behavior of immunosuppressive cells in tumors, turning them from cancer protectors into tumor fighters.